A total of 17,500 B shares were repurchased and a total of 25,491 treasury shares were sold to Novo Nordisk employees in relation to existing incentive programmes during the first quarter of 2001.
As previously announced the stock repurchasing programme initiated on 3 November 1999 was completed in February 2001. In total 2,535,250 shares have been repurchased under the programme at an average price of DKK 1,183. No further stock repurchasing programmes have been initiated at this point in time.
As previously announced the stock repurchasing programme initiated on 3 November 1999 was completed in February 2001. In total 2,535,250 shares have been repurchased under the programme at an average price of DKK 1,183. No further stock repurchasing programmes have been initiated at this point in time.
Please note that the above-mentioned number of B shares refer to shares of the old unit size of DKK 10. As a consequence of the 5 to 1 split of the B shares on 4 April 2001 the number of treasury shares is now five times higher or 31,517,205 in total. The stock split does not have any effect on the nominal value or the per cent of total capital stock that this holding of treasury shares represents.
This announcement is pursuant to Section 204.33, Treasury Stock Changes, of the New York Stock Exchange Listed Company Manual, and to Section 28 of the Danish Securities Trading Act.
For further information about the stock split please visit our homepage www.novonordisk.com - Investors - Share Information.
Novo Nordisk is a focused healthcare company and the world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as coagulation disorders, growth disorders and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 14,000 people in 68 countries and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADSs are listed on the New York Stock Exchange under the symbol 'NVO'. For further company information visit www.novonordisk.com
For further information please contact:
Media:
Outside North America
Elin K Hansen
Tel (direct): (+45) 4442 3450
Outside North America
Elin K Hansen
Tel (direct): (+45) 4442 3450
In North America:
Susan Toth Jackson
Tel: (+1) 212 867 0123
Susan Toth Jackson
Tel: (+1) 212 867 0123
Investors:
Outside North America
Peter Haahr
Tel (direct): (+45) 4442 1207
Outside North America
Peter Haahr
Tel (direct): (+45) 4442 1207
Palle Holm Olesen
Tel (direct): (+45) 4442 6175
Tel (direct): (+45) 4442 6175
In North America:
Rasmus Holm-Jørgensen
Tel: (+1) 212 878 9607
Stock Exchange Announcement No 8 / 2001
Rasmus Holm-Jørgensen
Tel: (+1) 212 878 9607
Stock Exchange Announcement No 8 / 2001